TD Cowen upgrades UnitedHealth to Buy and raises price target to $455

TD Cowen upgraded UnitedHealth Group (UNH) from Hold to Buy and lifted its price target to $455, up from $402. The broker expects mid‑to‑high‑teens adjusted EPS growth through 2028, with EPS projected at $23.57 in 2027 and $27.61 in 2028. The upgrade follows a Q3 2026 earnings beat and a modest 0.41% YoY decline in revenue to $112.7 billion.

The higher target implies roughly 16.5‑times 2028 EPS and suggests upside of about 37% from the current price, according to TD Cowen. Investors will watch whether the projected EPS growth materialises as the firm improves Medicare Advantage margins and Optum Health performance.

  • 1TD Cowen raised UnitedHealth's price target to $455 from $402.
  • 2The upgrade moves UnitedHealth to a Buy rating from Hold.
  • 3TD Cowen forecasts mid‑to‑high‑teens adjusted EPS growth through 2028.
  • 4TD Cowen projects adjusted EPS of $23.57 for 2027 and $27.61 for 2028.
  • 5UnitedHealth reported Q3 2026 revenue of $112.7 billion, down 0.41% YoY.
  • 6Analyst Ryan Langston named UnitedHealth the 2027 Best Idea.

Sources